PF-AtlasClinical Trials › NCT07519460

Effects of High-Frequency Chest Wall Oscillation Combined With Concurrent Training on Cough,in Cystic Fibrosis Patients

High-Frequency Chest Wall Oscillation · Not specified

Registry ID
NCT07519460
Phase
Not specified
Status
Not yet recruiting
Drug / intervention
High-Frequency Chest Wall Oscillation
Sponsor
Riphah International University
Start
2026-04
Enrollment
24
Locations
1

About this trial

This randomized clinical trial aims to evaluate the effects of high-frequency chest wall oscillation (HFCWO) combined with concurrent training on cough, sputum clearance, exercise tolerance, and respiratory muscle strength in patients with Cystic Fibrosis. A total of 24 participants meeting inclusion criteria will be randomly allocated into two groups: Group A will receive HFCWO plus concurrent training, while Group B will receive HFCWO alone for 8 weeks. Outcomes will be measured before and after intervention using the 6-minute walk test, spirometry, Leicester Cough Questionnaire, sputum volume, and the Cystic Fibrosis Questionnaire-Revised. The study will be conducted at Pulmonary Rehabilitation Unit, Gulab Devi Hospital and Mayo Hospital, Lahore. Statistical analysis will be performed using IBM SPSS Statistics, with significance set at p \< 0.05.

View NCT07519460 on ClinicalTrials.gov →

Explore related

Medical disclaimer. This page summarizes public trial data for NCT07519460 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.